92 related articles for article (PubMed ID: 2431260)
1. [Drug therapy of chronic active hepatitis].
Wegener M; Börsch G; Schmidt G
Med Klin (Munich); 1986 Mar; 81(6):223-5. PubMed ID: 2431260
[No Abstract] [Full Text] [Related]
2. [Antiviral treatment of chronic hepatitis].
Müller R
Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
[No Abstract] [Full Text] [Related]
3. Relapse following treatment withdrawal in autoimmune chronic active hepatitis.
McCullough AJ; Czaja AJ
Hepatology; 1984; 4(4):747-8. PubMed ID: 6745867
[No Abstract] [Full Text] [Related]
4. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
Causse X; Guérou V; Rougier P; Trépo C
Gastroenterol Clin Biol; 1993; 17(2):144-5. PubMed ID: 7684714
[No Abstract] [Full Text] [Related]
5. Autoimmune hepatitis.
Yarze JC
N Engl J Med; 1996 Apr; 334(14):923-4. PubMed ID: 8596591
[No Abstract] [Full Text] [Related]
6. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
[TBL] [Abstract][Full Text] [Related]
7. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Hoofnagle JH
J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B].
Le Quellec A; Bories P; Bauret P; Piera S; Ouzan D; Trepo C; Michel H
Gastroenterol Clin Biol; 1986 Oct; 10(10):687-8. PubMed ID: 2878855
[No Abstract] [Full Text] [Related]
9. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
Degos F; Marcellin P; Benhamou JP
Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
[No Abstract] [Full Text] [Related]
10. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
[No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy of chronic active hepatitis: results of a long-term follow-up].
Musca A; Cordova C; Barnaba V; Levrero M; Zaccari C; Trinchieri F; Gnecchi M
Clin Ter; 1983 Jun; 105(5):403-9. PubMed ID: 6872479
[No Abstract] [Full Text] [Related]
12. [Indications for drug therapy of chronic active hepatitis and posthepatitis liver cirrhosis].
Strohmeyer G; Lübke HJ
Dtsch Med Wochenschr; 1985 Jan; 110(3):104-5. PubMed ID: 3967586
[No Abstract] [Full Text] [Related]
13. Treatment of autoimmune hepatitis.
Johnson PJ
Gut; 1997 Jul; 41(1):3-4. PubMed ID: 9274462
[No Abstract] [Full Text] [Related]
14. [Treatment of chronic hepatitis B].
Carreño V; Montaño L; Torres M
Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
[No Abstract] [Full Text] [Related]
15. [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
Ouzan D
Rev Prat; 1992 Jun; 42(11):1383-6. PubMed ID: 1382310
[No Abstract] [Full Text] [Related]
16. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of chronic hepatitis].
Carrieri V; Ventrella F; Gadaleta CD
Clin Ter; 1986 May; 117(4):297-309. PubMed ID: 2426031
[No Abstract] [Full Text] [Related]
18. Chronic active hepatitis.
Kolts BE; Spindel E
Am Fam Physician; 1984 Jun; 29(6):228-43. PubMed ID: 6203393
[No Abstract] [Full Text] [Related]
19. Chronic hepatitis.
Fitzgerald JF
J Pediatr; 1984 Jun; 104(6):893-5. PubMed ID: 6233413
[No Abstract] [Full Text] [Related]
20. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
Slavin S
Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
